Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 207,326 | 61,536 | 54,857 | 65,126 | 49,296 |
| Marketable Securities | 90,588 | 2,404 | 20,237 | 29,690 | 34,492 |
| Receivables | 3,393 | 2,929 | 2,084 | 1,785 | 1,717 |
| TOTAL | $308,010 | $72,716 | $80,563 | $100,189 | $89,578 |
| Non-Current Assets | |||||
| PPE Net | 14,729 | 16,305 | 17,836 | 19,495 | 21,160 |
| Investments And Advances | 23,798 | 1,400 | 1,400 | 1,400 | 1,400 |
| Other Non-Current Assets | 9,664 | 10,257 | 10,820 | 11,356 | 12,013 |
| TOTAL | $48,191 | $27,962 | $30,056 | $32,251 | $34,573 |
| Total Assets | $356,201 | $100,678 | $110,619 | $132,440 | $124,151 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,201 | 4,163 | 5,521 | 4,859 | 4,455 |
| Accrued Expenses | 11,318 | 10,604 | 9,141 | 10,884 | 10,522 |
| TOTAL | $45,770 | $44,248 | $44,114 | $45,993 | $42,237 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,977 | 24,863 | 24,754 | 24,648 | N/A |
| Deferred Revenues | 23,301 | 24,693 | 24,829 | 25,794 | 22,925 |
| Other Non-Current Liabilities | 12,881 | 13,933 | 15,124 | 16,178 | 17,508 |
| TOTAL | $122,379 | $122,005 | $128,154 | $134,771 | $114,133 |
| Total Liabilities | $168,149 | $166,253 | $172,268 | $180,764 | $156,370 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,562 | 3,813 | 3,630 | 3,554 | 3,500 |
| Common Shares | 91 | 75 | 72 | 70 | 70 |
| Retained earnings | -530,524 | -500,244 | -479,530 | -459,649 | -440,871 |
| Other shareholders' equity | 2 | 1 | -10 | 0 | 7 |
| TOTAL | $188,052 | $-65,575 | $-61,649 | $-48,324 | $-32,219 |
| Total Liabilities And Equity | $356,201 | $100,678 | $110,619 | $132,440 | $124,151 |